experimental group:ruxolitinib

2 trials

Sponsors

Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, The Second Affiliated Hospital of Dalian Medical University

Conditions

Severe aplastic anemiaacute/chronic graft versus host disease

Phase 4

Study for Ruxolitinib as a Therapy of Pediatric Corticosteroid-Refractory Acute /Chronic Graft-Versus-Host Disease

RecruitingChiCTR2000033783

Beijing Children's Hospital, Capital Medical University, National Center for Children's Healthacute/chronic graft versus host disease

Start: 2020-06-03Updated: 2020-06-15

Unknown Phase

Efficacy and safety of ruxolitinib in preventing aGVHD after haplotype bone marrow transplantation in severe aplastic anemia

RecruitingChiCTR2100051874

The Second Affiliated Hospital of Dalian Medical UniversitySevere aplastic anemia

Start: 2021-10-01Updated: 2024-08-12